MATTHEW W FOEHR Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for MATTHEW W FOEHR.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of MATTHEW W FOEHR. MATTHEW W FOEHR is a President and COO in LIGAND PHARMACEUTICALS INC ($LGND) and a Sr. VP Technical Operations in CONNETICS CORP ($CNCT) and a Director in RITTER PHARMACEUTICALS INC ($RTTR) and a Director in Viking Therapeutics, Inc. ($VKTX).

Over the past year MATTHEW W FOEHR has been an insider in 3 companies. The total value of shares held by MATTHEW W FOEHR in these companies amounts to $13,821,143.

MATTHEW W FOEHR Sr. VP Technical Operations
CONNETICS CORP
President and COO
LIGAND PHARMACEUTICALS INC
Director
Qualigen Therapeutics, Inc.
Director
Viking Therapeutics, Inc.
$ 13821143 The total value of shares held by MATTHEW W FOEHR
Insider Rank

MATTHEW W FOEHR ranks 2,207 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: 3290 WEST BAYSHORE ROAD PALO ALTO 94303 CA

Companies in which MATTHEW W FOEHR is an Insider

CONNETICS CORP

Trading Symbol: CNCT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW W FOEHR: Sr. VP Technical Operations
Holdings: 7,331 shares
Current Value: $0
Latest Transaction: Apr 20 2005
$CNCT Market Capitalization: $389378.34
$CNCT Previous Close: $0.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

LIGAND PHARMACEUTICALS INC

Trading Symbol: LGND
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW W FOEHR: President and COO
Holdings: 124,615 shares
Current Value: $13,438,482
Latest Transaction: Apr 24 2020
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 40x
Sell: 29x
Shares Bought: 192,961
Shares Sold: 115,000
Share Difference: +77,961
Value Difference: +$15,713,386

Qualigen Therapeutics, Inc.

Trading Symbol: RTTR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW W FOEHR: Director
Holdings: 100,174 shares
Current Value: $344,599
Latest Transaction: Apr 23 2020
$RTTR Market Capitalization: $36.80M
$RTTR Previous Close: $3.44

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 153,135
Shares Sold: 0
Share Difference: +153,135
Value Difference: -$51,447

Viking Therapeutics, Inc.

Trading Symbol: VKTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MATTHEW W FOEHR: Director
Holdings: 26,250 shares
Current Value: $38,063
Latest Transaction: Jun 30 2020
$VKTX Market Capitalization: $31.36M
$VKTX Previous Close: $1.45

Last 4 weeks trend: HOLD
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 1x
Shares Bought: 33,000
Shares Sold: 13,000
Share Difference: +20,000
Value Difference: +$55,072

Latest Insider Trading Transactions of MATTHEW W FOEHR

Sentiment: All, CNCT, LGND, RTTR, VKTX

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 30 2020VKTXViking Therapeutic ...FOEHR MATTHEW WDirectorSellS7.3513,00095,55026,25039.3 K to 26.3 K (-33.12 %)
Apr 24 2020LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WPresident and COOPayment of ExerciseF120.8664277,592122,727123.4 K to 122.7 K (-0.52 %)
Apr 24 2020LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WPresident and COOPayment of ExerciseF120.861,246150,592123,369124.6 K to 123.4 K (-1.00 %)
Apr 24 2020LGNDLIGAND PHARMACEUTI ...FOEHR MATTHEW WPresident and COOPayment of ExerciseF120.86938113,367124,615125.6 K to 124.6 K (-0.75 %)
Apr 23 2020RTTRRITTER PHARMACEUTI ...FOEHR MATTHEW WDirectorOption ExerciseD1.3038,46149,9990
Apr 23 2020RTTRRITTER PHARMACEUTI ...FOEHR MATTHEW WDirectorOption ExerciseC1.301001300
Apr 23 2020RTTRRITTER PHARMACEUTI ...FOEHR MATTHEW WDirectorGrantA0.0038,4610138,635100.2 K to 138.6 K (+38.39 %)

View all MATTHEW W FOEHR insider transactions.